113 related articles for article (PubMed ID: 36974364)
1. Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer.
Qu H; Zhang Z; Zhang D; Okamoto T; Zhang P; Zhang H; Dong W
Thyroid; 2023 Oct; 33(10):1264-1267. PubMed ID: 36974364
[No Abstract] [Full Text] [Related]
2. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
3. Assessing non-aggressiveness of untreated, local and regional, papillary thyroid cancer.
van Gerwen M; Alpert N; Sinclair C; Kale M; Genden E; Taioli E
Oral Oncol; 2020 Jun; 105():104674. PubMed ID: 32279012
[TBL] [Abstract][Full Text] [Related]
4. Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?
Harries V; McGill M; Yuan A; Wang LY; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ganly I
Surgery; 2022 May; 171(5):1341-1347. PubMed ID: 34600743
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.
Schelfhout LJ; Creutzberg CL; Hamming JF; Fleuren GJ; Smeenk D; Hermans J; van de Velde CJ; Goslings BM
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):331-7. PubMed ID: 3356216
[TBL] [Abstract][Full Text] [Related]
6. Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data.
Zhang HS; Lee EK; Jung YS; Nam BH; Jung KW; Kong HJ; Won YJ; Park B
Surgery; 2019 Mar; 165(3):629-636. PubMed ID: 30342774
[TBL] [Abstract][Full Text] [Related]
7. Conditional survival in patients with thyroid cancer.
Banerjee M; Muenz DG; Worden FP; Wong SL; Haymart MR
Thyroid; 2014 Dec; 24(12):1784-9. PubMed ID: 25208475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
[TBL] [Abstract][Full Text] [Related]
10. Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Kwon JH; Yi JW
Surgery; 2021 Jan; 169(1):43-49. PubMed ID: 32641280
[TBL] [Abstract][Full Text] [Related]
11. Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
Dong W; Horiuchi K; Tokumitsu H; Sakamoto A; Noguchi E; Ueda Y; Okamoto T
Thyroid; 2019 Jun; 29(6):802-808. PubMed ID: 30931815
[No Abstract] [Full Text] [Related]
12. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
14. Causes of death and conditional survival estimates of long-term lung cancer survivors.
Zhang Q; Dai Y; Liu H; Sun W; Huang Y; Gong Z; Dai S; Kong H; Xie W
Front Immunol; 2022; 13():1012247. PubMed ID: 36211420
[TBL] [Abstract][Full Text] [Related]
15. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
18. Time to Surgery and Thyroid Cancer Survival in the United States.
Fligor SC; Lopez B; Uppal N; Lubitz CC; James BC
Ann Surg Oncol; 2021 Jul; 28(7):3556-3565. PubMed ID: 33768394
[TBL] [Abstract][Full Text] [Related]
19. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
[TBL] [Abstract][Full Text] [Related]
20. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.
Wang J; Huang X; Sun S; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Xiao J; Gao L; Xu G; Hu C; Li YX; Yi J
Cancer Med; 2021 Jun; 10(11):3613-3621. PubMed ID: 33960136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
